Chile’s public health institute and medicines regulator
Chile’s public health institute and medicines regulator
Chile’s former top drug regulator says faster approvals mean little if coverage stalls, and wants the medicines agency separated administratively from the Institute of Public Health.
Chileans spend nearly US$100 million a year on weight-loss treatment, according to La Tercera, as seven generic semaglutide applications — including Laboratorio Chile’s Selfix — await regulatory review, putting Novo …
You must be logged in to post a comment.